HK1212587A1 - Formulation for prevention or treatment of diabetes - Google Patents

Formulation for prevention or treatment of diabetes

Info

Publication number
HK1212587A1
HK1212587A1 HK16100385.5A HK16100385A HK1212587A1 HK 1212587 A1 HK1212587 A1 HK 1212587A1 HK 16100385 A HK16100385 A HK 16100385A HK 1212587 A1 HK1212587 A1 HK 1212587A1
Authority
HK
Hong Kong
Prior art keywords
diabetes
formulation
prevention
treatment
Prior art date
Application number
HK16100385.5A
Other languages
Chinese (zh)
Inventor
Eun Ji Kim
Hye Jung Park
Sang Jun Youn
Hyo Ju Park
Min Ju Hong
Hyo Ju Pyo
Yun Ah Jung
Hyun Wook Park
Yun Jung Kim
Geun Seog Song
Byoung Seok Moon
Kwi Man Kang
Original Assignee
Cj Healthcare Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cj Healthcare Corp filed Critical Cj Healthcare Corp
Publication of HK1212587A1 publication Critical patent/HK1212587A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
HK16100385.5A 2013-03-06 2016-01-14 Formulation for prevention or treatment of diabetes HK1212587A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020130024157A KR101336499B1 (en) 2013-03-06 2013-03-06 Combination composition for prevention or treatment of diabetes
PCT/KR2014/001455 WO2014137090A1 (en) 2013-03-06 2014-02-24 Formulation for prevention or treatment of diabetes

Publications (1)

Publication Number Publication Date
HK1212587A1 true HK1212587A1 (en) 2016-06-17

Family

ID=49987171

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16100385.5A HK1212587A1 (en) 2013-03-06 2016-01-14 Formulation for prevention or treatment of diabetes

Country Status (8)

Country Link
EP (1) EP2964211A4 (en)
JP (1) JP2016509065A (en)
KR (1) KR101336499B1 (en)
CN (1) CN104027328A (en)
BR (1) BR112015018934A2 (en)
HK (1) HK1212587A1 (en)
TW (1) TW201434463A (en)
WO (1) WO2014137090A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586438B2 (en) * 1999-11-03 2003-07-01 Bristol-Myers Squibb Co. Antidiabetic formulation and method
JP2009500401A (en) * 2005-07-07 2009-01-08 ポステック ファンデーション Sugar absorption regulator and pharmaceutical composition
CN101590007A (en) * 2008-05-27 2009-12-02 北京瑞伊人科技发展有限公司 A kind of metformin hydrochloride/voigelibo sugar-lowering oral preparation compositions and preparation thereof
KR101189639B1 (en) * 2008-12-15 2012-10-12 씨제이제일제당 (주) Oral formulations comprising metformin and &-glycosidase inhibitor and processes for the preparation thereof
CN102133402B (en) * 2011-03-24 2013-06-12 首都医科大学附属北京同仁医院 Application of cystic fibrosis transmembrane transduction regulating factor inhibitor to preparation of medicaments for treating diabetes

Also Published As

Publication number Publication date
TW201434463A (en) 2014-09-16
BR112015018934A2 (en) 2017-07-18
EP2964211A4 (en) 2016-08-31
JP2016509065A (en) 2016-03-24
EP2964211A1 (en) 2016-01-13
WO2014137090A1 (en) 2014-09-12
KR101336499B1 (en) 2013-12-03
CN104027328A (en) 2014-09-10

Similar Documents

Publication Publication Date Title
IL243976A0 (en) Kdm1a inhibitors for the treatment of disease
SG11201509782TA (en) Compositions and methods for the treatment of diabetes and pre-diabetes
HK1202458A1 (en) Glucokinase activator compositions for the treatment of diabetes
EP3065768A4 (en) Therapy for treatment or prevention of conditions associated with bleeding or hypocoagulation
EP2867239A4 (en) Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetes
HK1217443A1 (en) Pharmaceutical compositions for oral treatment of diabetes
PL2812013T3 (en) Formulation for the treatment of ibs
SG10201705899XA (en) Prevention & treatment of neuropathy
HK1220374A1 (en) Compositions and methods for the treatment of carboxyhemoglobinemia
EP2986294A4 (en) Compounds for treatment of pain
ZA201408065B (en) Compositions and methods for the treatment of diabetes
EP3104869A4 (en) Treatment of pain
EP2958572A4 (en) Treatment of hyperhidrosis
ZA201602888B (en) Compounds for the treatment of diabetes and disease complications arising from same
ZA201506396B (en) Use of sedoheptulose for prevention or treatment of inflammation
HRP20181445T1 (en) Compositions and methods for treatment of type 1 diabetes
HK1212587A1 (en) Formulation for prevention or treatment of diabetes
EP2986295A4 (en) Compounds for treatment of pain
IL245496A0 (en) Compounds for the treatment of diabetes and disease complications arising from same
IL240119A0 (en) Pharmaceutical compositions for oral treatment of diabetes
ZA201404780B (en) Composition for use in treatment of diabetes
GB201308665D0 (en) Device for the treatment of bone conditions
AU2013905080A0 (en) Treatment of Pain
GB201316698D0 (en) Use of tri-substituted glycerol compounds for prevention and treatment of allo-immune disorders
GB201308539D0 (en) Liquid treatment